DIFESA CAPITAL MANAGEMENT, LP - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.

Quarter-by-quarter ownership
DIFESA CAPITAL MANAGEMENT, LP ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$199,320
-26.5%
11,000
+7.8%
0.52%
+194.4%
Q1 2023$271,320
+37.6%
10,2000.0%0.18%
+16.3%
Q4 2022$197,166
-7.4%
10,2000.0%0.15%
+41.7%
Q3 2022$213,000
+159.8%
10,2000.0%0.11%
+129.8%
Q2 2022$82,000
+13.9%
10,2000.0%0.05%
+30.6%
Q1 2022$72,000
-47.8%
10,2000.0%0.04%
-61.7%
Q4 2021$138,00010,2000.09%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 339,160$5,881,034100.00%
CHI Advisors LLC 3,014,199$52,266,21120.72%
TRV GP IV, LLC 2,132,867$36,983,91413.93%
GREAT POINT PARTNERS LLC 1,755,184$30,434,8915.54%
First Light Asset Management, LLC 2,933,260$50,862,7284.83%
Deep Track Capital, LP 5,500,000$95,370,0003.68%
Casdin Capital, LLC 1,577,108$27,347,0533.03%
Fernwood Investment Management, LLC 379,702$6,584,0332.37%
Redmile Group, LLC 2,678,099$46,438,2372.21%
SILVERARC CAPITAL MANAGEMENT, LLC 250,409$4,342,0921.32%
View complete list of PLIANT THERAPEUTICS INC shareholders